Allovir, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Allovir, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Allovir, Inc. Return On Equity for the quarter ending June 30, 2024 was -96.5 %, a 30.3% decline year-over-year.
  • Allovir, Inc. annual Return On Equity for 2023 was -99.7 %, a 22.3% decline from 2022.
  • Allovir, Inc. annual Return On Equity for 2022 was -81.6 %, a 33.4% decline from 2021.
  • Allovir, Inc. annual Return On Equity for 2021 was -61.1 %, a 30.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -99.7 -18.2 -22.3% Jan 1, 2023 Dec 31, 2023
2022 -81.6 -20.4 -33.4% Jan 1, 2022 Dec 31, 2022
2021 -61.1 -14.3 -30.4% Jan 1, 2021 Dec 31, 2021
2020 -46.9 -105 -181% Jan 1, 2020 Dec 31, 2020
2019 58 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.